EW DEADLINE TODAY: ROSEN, A LEADING LAW FIRM, Encourages Edwards Lifesciences Corporation Investors to Secure Counsel Before Important December 13 Deadline in Securities Class Action - EW Dec 13, 2024 05:40PM
EW DEADLINE TOMORROW: ROSEN, A LEADING LAW FIRM, Encourages Edwards Lifesciences Corporation Investors with Losses in Excess of $100k to Secure Counsel Before Important December 13 Deadline in Securit Dec 12, 2024 05:35PM
Five-Year Data Show Excellent Outcomes for Female and Small Annulus Patients With Edwards TAVR Jun 5, 2024 11:45AM
Becton Dickinson (BDX) to Acquire Edwards Lifesciences' (EW) Critical Care Product Group for $4.2B Cash Jun 3, 2024 06:30AM
BD to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2 Billion to Expand Smart Connected Care Solutions and Become an Advanced Monitoring Technology Leader Jun 3, 2024 06:30AM
View Older Stories

Apr 7, 2024 04:30PM Study of NFL Alumni Cohort Finds Majority Suffer From Heart Disease Without Knowing It
Mar 11, 2024 02:00PM Large, Real-world Studies Demonstrate Continued Excellent Outcomes for Patients Receiving Edwards SAPIEN TAVR
Jan 30, 2024 07:05AM Edwards Lifesciences to Host Earnings Conference Call on February 6, 2024
Jan 2, 2024 09:00AM Edwards Lifesciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Dec 7, 2023 08:35AM Edwards Lifesciences (EW) sees FY24 adjusted earnings per share of $2.70 - $2.80
Dec 7, 2023 08:30AM Edwards Lifesciences Outlines Growth Strategy at Annual Investor Conference
Oct 26, 2023 03:06PM CLASP IID ONE-YEAR DATA CONFIRM SAFETY AND EFFICACY OF EDWARDS PASCAL SYSTEM FOR DEGENERATIVE MITRAL REGURGITATION
Oct 26, 2023 02:00PM TRISCEND II SIX-MONTH DATA FOR FIRST 150 PATIENTS SUCCESSFULLY DEMONSTRATE SAFETY AND EFFICACY OF EDWARDS EVOQUE SYSTEM FOR SEVERE TRICUSPID REGURGITATION
Oct 25, 2023 04:15PM EDWARDS LIFESCIENCES REPORTS THIRD QUARTER RESULTS
Oct 24, 2023 02:10PM Edwards Lifesciences (EW) Says Five-year Data From Partner 3 Trial Demonstrate Excellent Survival For Patients Receiving Sapien 3 Valve
Oct 24, 2023 02:00PM FIVE-YEAR DATA FROM PARTNER 3 TRIAL DEMONSTRATE EXCELLENT SURVIVAL FOR PATIENTS RECEIVING EDWARDS SAPIEN 3 VALVE
Oct 18, 2023 07:05AM EDWARDS LIFESCIENCES TO HOST EARNINGS CONFERENCE CALL ON OCTOBER 25, 2023
Aug 28, 2023 08:10AM EDWARDS LIFESCIENCES TO PRESENT AT THE 2023 WELLS FARGO HEALTHCARE CONFERENCE
Jul 26, 2023 04:15PM EDWARDS LIFESCIENCES REPORTS SECOND QUARTER RESULTS
Jul 19, 2023 07:05AM EDWARDS LIFESCIENCES TO HOST EARNINGS CONFERENCE CALL ON JULY 26, 2023
May 17, 2023 04:30AM DATA FROM BENCHMARK REGISTRY DEMONSTRATE IMPROVED TAVR EFFICIENCY WITH PRESERVED PATIENT SAFETY
May 7, 2023 08:00PM EDWARDS' AORTIC VALVE WITH RESILIA TISSUE SHOWS FAVORABLE DURABILITY, SAFETY AND EFFICACY OUTCOMES IN SEVEN YEAR DATA
Apr 26, 2023 04:15PM EDWARDS LIFESCIENCES REPORTS FIRST QUARTER RESULTS
Apr 19, 2023 07:05AM EDWARDS LIFESCIENCES TO HOST EARNINGS CONFERENCE CALL ON APRIL 26, 2023
Mar 6, 2023 09:00AM EDWARDS HIGHLIGHTS NEW DATA AT ACC RELATED TO LIFETIME MANAGEMENT OF AORTIC STENOSIS
Jan 31, 2023 04:15PM EDWARDS LIFESCIENCES REPORTS FOURTH QUARTER RESULTS
Jan 24, 2023 07:05AM EDWARDS LIFESCIENCES TO HOST EARNINGS CONFERENCE CALL ON JANUARY 31, 2023
Jan 5, 2023 09:05AM EDWARDS LIFESCIENCES TO PRESENT AT THE 41ST ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
Dec 8, 2022 05:38PM 3 stock rumors being discussed on trading floors today
Dec 8, 2022 08:09AM Edwards Lifesciences (EW) Announces CEO Succession Plan
Dec 8, 2022 08:01AM EDWARDS LIFESCIENCES OUTLINES GROWTH STRATEGY AT ANNUAL INVESTOR CONFERENCE
Dec 8, 2022 08:00AM EDWARDS LIFESCIENCES ANNOUNCES CEO SUCCESSION PLAN
Nov 28, 2022 06:43AM Edwards Lifesciences (EW) Announces EVOQUE transcatheter tricuspid valve replacement system shows 90.1% survival at one year
Nov 27, 2022 10:25AM EDWARDS ANNOUNCES ONE-YEAR DATA ON TRANSFEMORAL TRANSCATHETER TRICUSPID VALVE REPLACEMENT
Nov 1, 2022 09:01AM Edwards Lifesciences (EW) Announces Accelerated $750M Share Buyback
Nov 1, 2022 09:00AM EDWARDS LIFESCIENCES ANNOUNCES $750 MILLION ACCELERATED SHARE REPURCHASE
Oct 27, 2022 04:15PM EDWARDS LIFESCIENCES REPORTS THIRD QUARTER RESULTS
Oct 20, 2022 07:05AM EDWARDS LIFESCIENCES TO HOST EARNINGS CONFERENCE CALL ON OCTOBER 27, 2022
Sep 17, 2022 11:30AM EDWARDS ANNOUNCES SIX-MONTH DATA CONFIRMING TEER AS SAFE AND EFFECTIVE FOR DMR IN FIRST HEAD-TO-HEAD TRIAL
Sep 15, 2022 09:42AM Edwards Lifesciences (EW) Pascal Precision Transcatheter Valve Repair System Receives Fda Approval For Degenerative Mitral Regurgitation (earlier)
Sep 15, 2022 09:00AM EDWARDS PASCAL PRECISION TRANSCATHETER VALVE REPAIR SYSTEM RECEIVES FDA APPROVAL FOR DEGENERATIVE MITRAL REGURGITATION
Sep 12, 2022 09:06AM Edwards Lifesciences (EW) Launches Sapien 3 Ultra Resilia Valve Following Fda Approval
Sep 12, 2022 09:05AM EDWARDS LAUNCHES SAPIEN 3 ULTRA RESILIA VALVE FOLLOWING FDA APPROVAL
Aug 17, 2022 08:30AM EDWARDS PASCAL PRECISION TRANSCATHETER MITRAL AND TRICUSPID VALVE REPAIR SYSTEM RECEIVES CE MARK
Jul 28, 2022 04:15PM EDWARDS LIFESCIENCES REPORTS SECOND QUARTER RESULTS
Jul 21, 2022 07:05AM EDWARDS LIFESCIENCES TO HOST EARNINGS CONFERENCE CALL ON JULY 28, 2022
May 23, 2022 08:10AM EDWARDS LIFESCIENCES TO PRESENT AT THE BERNSTEIN 38TH ANNUAL STRATEGIC DECISIONS CONFERENCE
May 16, 2022 09:15AM EDWARDS ANNOUNCES KEY EVENTS FOR EUROPCR 2022
Apr 26, 2022 04:15PM EDWARDS LIFESCIENCES REPORTS FIRST QUARTER RESULTS
Apr 19, 2022 07:05AM EDWARDS LIFESCIENCES TO HOST EARNINGS CONFERENCE CALL ON APRIL 26, 2022
Jan 26, 2022 04:15PM EDWARDS LIFESCIENCES REPORTS FOURTH QUARTER RESULTS
Jan 19, 2022 07:05AM EDWARDS LIFESCIENCES TO HOST EARNINGS CONFERENCE CALL ON JANUARY 26, 2022
Jan 5, 2022 08:10AM EDWARDS LIFESCIENCES TO PRESENT AT THE 40TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
Dec 20, 2021 09:09AM Edwards Lifesciences (EW) Granted FDA Approval for SAPIEN 3 Transcatheter Valve
Dec 20, 2021 09:05AM EDWARDS RECEIVES FDA APPROVAL FOR SAPIEN 3 WITH ALTERRA PRESTENT FOR TRANSCATHETER PULMONIC VALVE REPLACEMENT
View Older Stories